Loading...
NPI 1205834769 · Rye Brook, NY · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Cblpath, Inc is a clinical medical laboratory provider located in Rye Brook, New York. This profile covers 52 Medicare and 32 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Cblpath, Inc |
| Address | 760 Westchester Ave |
| City | Rye Brook |
| State | NY |
| ZIP | 10573 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 8, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $9.7M |
| Medicare | $8M |
CBLPATH, INC operates as a high-volume clinical pathology and molecular diagnostics laboratory: its Medicare billing is led by surgical pathology (88305 — 36.2K claims, $2.2M revenue) alongside a proprietary molecular PLA (0026U — 506 claims, $1.8M revenue) and cytopathology (88173 — 7.6K claims, $1.1M revenue), while Medicaid shows the same mix with 0026U driving $4.3M on 5.2K claims and 88305 generating $2.5M on 66.2K claims. This combination of high-volume histopathology/ IHC work plus a revenue-heavy proprietary molecular test indicates the vendor provides both routine surgical pathology services and specialized genetic testing at scale.
Revenue is concentrated in a very small set of tests: the precomputed top-3 Medicare codes account for 63.4% of Medicare revenue and the top-3 Medicaid codes account for 77.6% of Medicaid revenue. That concentration — dominated by 88305, 0026U, and 88173 across the two payers — suggests financial performance is highly sensitive to pricing, coverage, or utilization changes for those specific services.
The provider’s payer mix is balanced but Medicaid is slightly larger: reported lifetime Medicare revenue is $8M versus $9.7M in Medicaid revenue. Both payers are material to the business, so operational or contract shifts on either side could meaningfully affect overall revenue.
CBLPATH shows exceptional national standing on several Medicare codes: 88305 ranks #29 of 14580 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), 88173 ranks #2 of 4276 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), and 88361 ranks #3 of 634 providers nationally (100th percentile; notably above typical national volume for this code). For 0026U the file shows rank #1 of 1 providers nationally with no national peer volume comparison available, which reflects that the lab is the exclusive reporter for that PLA in the Medicare dataset.
State-level (Medicaid) competitive positioning is also concentrated and dominant for selected services: 0026U ranks #1 of 1 providers in-state (no state peer volume comparison available), 88305 ranks #4 of 642 providers in-state (100th percentile; extreme outlier, far above typical state volume for this code), and 88173 ranks #1 of 54 providers in-state (100th percentile; extreme outlier, far above typical state volume for this code). These ranks indicate CBLPATH is a major in-state provider for both routine pathology and several specialized tests.
Several individual codes are labeled as statistical outliers in the supplied comparisons, which signals atypical scale for those services: Medicare entries for 88305, 88173, 88341, 88342 and 88304 are described as "extreme outlier" or "notably above typical national volume," while many molecular codes (0026U and multiple Tier-2 molecular CPTs in Medicaid) show either no peer comparison or exclusive-state/provider reporting. From an examiner’s perspective this pattern points to unusually high concentration in a handful of complex pathology and molecular services rather than broad-based low-intensity billing.
Operational mix data shows deep capability across immunohistochemistry and ancillary testing: Medicare lists 9.6K claims for 88341 ($759.2K), 5.2K claims for 88342 ($470.4K), and 5.4K claims for 88361 ($581K), and Medicaid mirrors high volumes for 88342 (17.1K claims, $666.9K) and 88341 (5.5K claims, $444.2K). Coupled with flow cytometry-related codes (88185, 88184) and multiple molecular/genetic CPTs (e.g., 81261, 81264, 81404/81405 entries in Medicaid), the mix is consistent with an integrated pathology lab that performs slide-based diagnostics, IHC/FISH/flow, and commercial molecular panel testing.
CBLPATH’s NPI has been enumerated since 2005-07-08 (~21 years ago), indicating a long-tenured presence in the market; combined with the high ranks on multiple codes, this tenure supports an interpretation of an established laboratory operation rather than a recent entrant. Analysts evaluating contracting or competitive strategy should treat CBLPATH as an experienced regional/national participant for the specific pathology and molecular services it reports at scale.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
52 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 36,210 | $60 | $2.2M |
| 0026U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code describes only one unique lab test made by a specific manufacturer or performed by a specific lab. Code 0026U describes… | 510 | $3,510 | $1.8M |
| 88173 | The lab analyst performs the technical lab test to analyze a cytopathology specimen from a fine needle aspirate and then interprets and reports the results. | 7,610 | $150 | $1.1M |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 9,610 | $80 | $759.2K |
| 88361 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides using computer assisted… | 5,380 | $110 | $581K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 5,230 | $90 | $470.4K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 530 | $370 | $196.5K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 1,680 | $110 | $182.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 7,250 | $20 | $166.7K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 1,010 | $60 | $61.8K |
Showing 1–10 of 52
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 52 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
52 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 0026U | 1 | 10 | 510 | $3,510 | $1.8M |
| 88361 | 2 | 10 | 100 | $60 | $554.4K |
| 88120 | 14 | 30 | 90 | $450 | $133.6K |
| 88185 | 12 | 100 | 1,210 | $20 | $74.9K |
| 88305 | 3 | 980 | 370 | $50 | $58.5K |
| 88377 | 7 | 50 | 50 | $210 | $50.8K |
| 88312 | 45 | 430 | 70 | $70 | $24.6K |
| 88237 | 8 | 10 | 70 | $140 | $20.4K |
| 88264 | 5 | 10 | 90 | $140 | $19.7K |
| 88350 | 8 | 50 | 240 | $60 | $19K |
Showing 1–10 of 52
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
32 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0026U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code describes only one unique lab test made by a specific manufacturer or performed by a specific lab. Code 0026U describes… | 5,220 | $830 | $4.3M |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 66,150 | $40 | $2.5M |
| 88173 | The lab analyst performs the technical lab test to analyze a cytopathology specimen from a fine needle aspirate and then interprets and reports the results. | 18,290 | $40 | $676.9K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 17,100 | $40 | $666.9K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 5,480 | $80 | $444.2K |
| 88361 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides using computer assisted… | 3,040 | $80 | $230.7K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 900 | $230 | $207.5K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 5,010 | $20 | $115.2K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 2,490 | $30 | $77.3K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 2,630 | $30 | $73.6K |
Showing 1–10 of 32
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
32 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 0026U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code describes only one unique lab test made by a specific manufacturer or performed by a specific lab. Code 0026U describes… | 1 | 10 | 5,220 | $830 | $4.3M |
| 88361 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides using computer assisted… | 2 | 10 | 3,040 | $110 | $934.7K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 4 | 640 | 1,080 | $60 | $251.5K |
| 88120 | The lab analyst performs a technical lab test on a urinary tract specimen using in situ hybridization and three to five molecular probes for manual morphometric analysis, looking at the number and… | 13 | 20 | 380 | $210 | $232.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 14 | 40 | 480 | $200 | $223.6K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 45 | 260 | 310 | $80 | $112.4K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 11 | 10 | 210 | $260 | $105.9K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 4 | 340 | 510 | $50 | $80K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 36 | 270 | 230 | $60 | $75.2K |
| 81405 | The lab analyst performs the technical lab tests to complete one of the specific genetic analyses listed in this Tier 2, Level 6 molecular pathology code. | 7 | 10 | 440 | $160 | $67.1K |
Showing 1–10 of 32
Other providers in the same ZIP code as Cblpath, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Mrs. G's Services, LLC | NY | Home Health Agency | $0 | $103.2M |
| Principle Homecare | NY | Home Health Agency | $0 | $23.9M |
| Family Services Of Westchester, Inc. | NY | Community/Behavioral Health Agency | $0 | $22.7M |
| Open Door Family Medical Center Inc | NY | Federally Qualified Health Center (FQHC) | $0 | $19.5M |
| Port Chester-rye-rye Brook Emergency Medical Services Inc | NY | Ambulance | $860.8K | $1.4M |
| Gail Calamari | NY | Diagnostic Radiology Physician | $707.5K | $30 |
| Jesus Lago | NY | Psychiatry Physician | $235.4K | $111.1K |
| Russell Cavallo | NY | Sports Medicine (Orthopaedic Surgery) Physician | $265.2K | $0 |
| Robin Carlucci-murphy | NY | Podiatrist | $231.1K | $0 |
| Carlos Rueda | NY | Geriatric Psychiatry Physician | $183.1K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.